Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study
(Q52068162)
scientific article published on December 1, 1988
scientific article published on December 1, 1988
Language:
Current Data About
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study